The Recall Desk
HighFDA (Food)·F-1094-2024·Announced 2024-04-03

Himalayan Pain Relief Tea Contains Undeclared Pharmaceutical Drugs

WS Global Inc is recalling Himalayan Pain Relief Tea nationwide due to undeclared pharmaceutical drugs—Diclofenac and Dexamethasone Acetate—that were not listed on the product label.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II recall involving undeclared pharmaceutical drugs in a food product. No illnesses or injuries are reported in the source material. The undeclared drugs present a risk of harm to consumers, meeting the criterion for High severity.

Plain-English summary

WS Global Inc is recalling Himalayan Pain Relief Tea for Gout and Hangover distributed nationwide in the United States. All product codes on the market are included in this recall. The FDA classified this as a Class II recall.

The product contains undeclared drugs: Diclofenac and Dexamethasone Acetate. These pharmaceutical ingredients were not declared on the product label, creating a health risk for consumers who may not be aware of their presence in the product.

Consumers who have purchased this product should stop using it immediately. Anyone who has consumed the product should consult a healthcare provider if they experience any adverse health effects.

The recalled product

Product
Himalayan Pain Relief Tea for Gout and Hangover
Manufacturer
WS Global Inc
Hazard
  • undeclared-drugs
  • diclofenac
  • dexamethasone-acetate

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • all codes on us market

Distribution

Distributed nationwide across the United States.